Das Konzept der chronisch obstruktiven Lungenerkrankung (COPD) gerät ins Wanken. Bisher ging man davon aus, dass vor allem Raucher in der zweiten Lebenshälfte betroffen sind. Doch die Krankheit scheint viel früher zu beginnen. Hat das therapeutische Konsequenzen?
This is a preview of subscription content, log in via an institution to check access.
Literatur
Vogelmeier C, Buhl R, Burghuber O et al. Leitlinie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 2018; 72: 253–308
Committee GE. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2019 Report. www.goldcopd.com 2018, DOI
Kohansal R, Martinez-Camblor P, Agusti A et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180: 3–10
Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329–332
Soriano JB, Polverino F, Cosio BG. What is early COPD and why is it important? Eur Respir J 2018; 52
McDonough JE, Yuan R, Suzuki M et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567–1575
Koo HK, Vasilescu DM, Booth S et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med 2018; 6: 591–602
Sze MA, Dimitriu PA, Suzuki M et al. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2015; 192: 438–445
Sanchez-Salcedo P, Divo M, Casanova C et al. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model. Eur Respir J 2014; 44: 324–331
Hurst JR, Vestbo J, Anzueto A et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE). N Engl J Med 2010; 363: 1128–1138
Hurst JR, Vestbo J, Anzueto A et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128–1138
Scanlon PD, Connett JE, Waller LA et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000; 161: 381–390
Pauwels RA, Lofdahl C-G, Laitinen LA et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340: 1948–1953
Burge PS. EUROSCOP, ISOLDE and the Copenhagen City Lung Study. Thorax 1999; 54: 287–288
Jarad NA, Wedzicha JA, Burge PS et al. An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group. Respir Med 1999; 93: 161–166
Tashkin DP, Celli BR, Kesten S et al. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J 2010; 35: 287–294
Zhou Y, Zhong NS, Li X et al. Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease. N Engl J Med 2017; 377: 923–935
Di Marco F, Balbo P, de Blasio F et al. Early management of COPD: where are we now and where do we go from here? A Delphi consensus project. Int J Chron Obstruct Pulmon Dis 2019; 14: 353–360
Welte T, Vogelmeier C, Papi A. COPD: early diagnosis and treatment to slow disease progression. Int J Clin Pract 2015; 69: 336–349
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gillissen, A. Die COPD scheint früher zu beginnen als bisher angenommen. MMW - Fortschritte der Medizin 161, 35–38 (2019). https://doi.org/10.1007/s15006-019-0554-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-019-0554-0